Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Antares Pharma (ATRS)

Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor

/PRNewswire/ -- Dimension Inx, a biomaterials platform company developing therapeutics that restore tissue and organ function, announced today the appointments...

SGTX : 22.47 (-2.56%)
ATRS : 5.59 (unch)
VCEL : 48.23 (+0.50%)
ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Antares Pharma, Inc. (NasdaqCM: ATRS) to Halozyme...

ATRS : 5.59 (unch)
HALO : 43.82 (-0.23%)
ANTARES PHARMA INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Antares Pharma, Inc. - ATRS

Kuznicki Law PLLC is investigating the proposed sale of Antares Pharma, Inc. (NasdaqCM: ATRS) to Halozyme Therapeutics, Inc. (NasdaqGS: HALO). Under the terms of the proposed transaction, shareholders...

ATRS : 5.59 (unch)
HALO : 43.82 (-0.23%)
Assertio (ASRT) to Report Q1 Earnings: What's in the Cards?

On Assertio Holdings' (ASRT) Q1 earnings call, investors will focus on the sales performance of its marketed products.

NVAX : 15.50 (+2.31%)
ACET : 1.4900 (-2.61%)
ATRS : 5.59 (unch)
ASRT : 1.0000 (-0.99%)
ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Antares Pharma, Inc. (NasdaqCM: ATRS) to Halozyme...

ATRS : 5.59 (unch)
HALO : 43.82 (-0.23%)
Halozyme (HALO) to Acquire Antares for Auto Injector Platform

Halozyme (HALO) is set to acquire Antares for $960 million by June. The acquisition will add Antares' auto injector platform to Halozyme's portfolio and complement its promising ENHANZE technology.

GSK : 45.12 (-0.07%)
PFE : 28.88 (+0.66%)
HALO : 43.82 (-0.23%)
ATRS : 5.59 (unch)
Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing

Palm Beach, FL – April 14, 2022 – FinancialNewsMedia.com News Commentary – CAR-T therapy is a sort of treatment in which a patient’s T cells which is a type of immune system cell, are genetically...

ONCY : 1.0900 (+2.83%)
ONC.TO : 1.49 (+2.76%)
GSK : 45.12 (-0.07%)
SRRA : 54.99 (+0.04%)
ATRS : 5.59 (unch)
CLVS : 0.0812 (-5.58%)
TPTX : 76.01 (+0.69%)
Antares Pharma (ATRS) Moves 49.2% Higher: Will This Strength Last?

Antares Pharma (ATRS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

ATRS : 5.59 (unch)
BDX : 228.79 (-0.68%)
Delta, Fastenal rise; JPMorgan Chase, NanoString fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:

ASH : 99.65 (+1.64%)
FAST : 66.02 (+0.33%)
ATRS : 5.59 (unch)
DAL : 51.84 (+1.25%)
JPM : 200.71 (+1.92%)
Why Is Sierra Oncology (SRRA) Stock Up Today?

Sierra Oncology is soaring following big acquisition news

SRRA : 54.99 (+0.04%)
ATRS : 5.59 (unch)
GILD : 65.68 (-0.74%)
HALO : 43.82 (-0.23%)
GSK : 45.12 (-0.07%)

Barchart Exclusives

3 Highest-yielding Utility Stocks To Buy And Hold Forever
Add high-income to your portfolio with these 3 utility companies. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar